|

Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®

RECRUITINGSponsored by P+F Products + Features GmbH
Actively Recruiting
SponsorP+F Products + Features GmbH
Started2022-04-20
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05114850

Summary

Retrospective prospective Multicentric clinical follow up of patients with severe tricuspid regurgitation after being treated with the TricValve® Transcatheter Bicaval Valves System.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Successful treatment with TricValve Transcatheter Bicaval Valves System
* Patient/patient's authorized legal guardian gives his consent to participate in the study and signed the corresponding inform consent

Exclusion Criteria:

* no exclusion criterion

Conditions7

Heart DiseaseHeart DiseasesHeart FailureHeart Valve DiseasesTricuspid InsufficiencyTricuspid RegurgitationTricuspid Valve Insufficiency

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.